Lauren White
Vermogen: 121 909 $ op 31-05-2026
Vermogen: 121 909 $ op 31-05-2026
Lauren A. White is currently Chief Financial Officer at Seaport Therapeutics, Inc. since 2024.
Former roles include Chief Financial Officer & Senior Vice President at ImmunoGen, Inc. from 2023 to 2024, Treasurer, Chief Financial & Accounting Officer at C4 Therapeutics, Inc. from 2021 to 2023, and VP, Global Head-Business Planning & Analysis at Novartis Institutes for Biomedical Research, Inc. Education includes an MBA from Harvard Business School conferred in 2007 and an undergraduate degree from Wallace E Carroll School of Management conferred in 2000.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,01% | 04-05-2026 | 6.702 ( 0,01% ) | 121 909 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOGEN, INC. | Financieel Directeur/CFO | 01-01-2024 |
| C4 THERAPEUTICS, INC. | Financieel Directeur/CFO | 15-09-2023 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wallace E Carroll School of Management
Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau